NCT01178099 - An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Anemia, Sickle Cell

Interventions

DRUG

Prasugrel

Oral, daily for 12 days

Trial Locations (1)

SE 1 1YR

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London